Vounatsos, Maraganore to advise Legend
Plus: Kawakami becomes president of Mitsubishi’s U.S. unit and updates from InCarda, Bicycle, Arvinas, Heron, AnHeart and more
Cell therapy company Legend Biotech Corp. (NASDAQ:LEGN) appointed Michel Vounatsos, the former CEO of Biogen Inc. (NASDAQ:BIIB), and John Maraganore, the former CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), to its newly formed strategic advisory board.
Yasutoshi Kawakami became the president of Mitsubishi Tanabe Pharma America Inc. (MTPA) following the merger of Mitsubishi Tanabe Pharma Holdings America Inc. and Mitsubishi Tanabe Pharma Development America Inc. He succeeds Atsushi “Andy” Fujimoto, who will return to Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) in Japan. In addition to his new role, Kawakami is VP, head of U.S. and Europe business at the parent company. MTPA is now the only subsidiary of the Japanese parent company in the U.S. ...